"Gamma Rays" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source.
| Descriptor ID |
D005720
|
| MeSH Number(s) |
G01.358.500.505.300 G01.750.250.300 G01.750.750.400
|
| Concept/Terms |
Gamma Rays- Gamma Rays
- Gamma Ray
- Ray, Gamma
- Rays, Gamma
- Radiation, Gamma
- Gamma Radiation
- Gamma Radiations
- Radiations, Gamma
X-Rays, Nuclear- X-Rays, Nuclear
- Nuclear X-Ray
- X Rays, Nuclear
- X-Ray, Nuclear
- Nuclear X-Rays
- Nuclear X Rays
|
Below are MeSH descriptors whose meaning is more general than "Gamma Rays".
Below are MeSH descriptors whose meaning is more specific than "Gamma Rays".
This graph shows the total number of publications written about "Gamma Rays" by people in this website by year, and whether "Gamma Rays" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 4 | 5 |
| 2011 | 2 | 0 | 2 |
| 2013 | 4 | 0 | 4 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gamma Rays" by people in Profiles.
-
Yu H, Aravindan N, Xu J, Natarajan M. Inter- and intra-cellular mechanism of NF-kB-dependent survival advantage and clonal expansion of radio-resistant cancer cells. Cell Signal. 2017 02; 31:105-111.
-
Lau A, Ahmad S, Chen Y. A simulation study investigating a Cherenkov material for use with the prompt gamma range verification in proton therapy. J Xray Sci Technol. 2016 05 02; 24(4):565-82.
-
Aravindan S, Natarajan M, Ramraj SK, Pandian V, Khan FH, Herman TS, Aravindan N. Abscopal effect of low-LET ?-radiation mediated through Rel protein signal transduction in a mouse model of nontargeted radiation response. Cancer Gene Ther. 2014 Feb; 21(2):54-9.
-
Ungvari Z, Podlutsky A, Sosnowska D, Tucsek Z, Toth P, Deak F, Gautam T, Csiszar A, Sonntag WE. Ionizing radiation promotes the acquisition of a senescence-associated secretory phenotype and impairs angiogenic capacity in cerebromicrovascular endothelial cells: role of increased DNA damage and decreased DNA repair capacity in microvascular radiosensitivity. J Gerontol A Biol Sci Med Sci. 2013 Dec; 68(12):1443-57.
-
Aravindan S, Natarajan M, Herman TS, Awasthi V, Aravindan N. Molecular basis of 'hypoxic' breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling. Radiat Oncol. 2013 Mar 04; 8:46.
-
Lau A, Chen Y, Ahmad S. Range verification of proton radiotherapy with prompt gamma rays. J Xray Sci Technol. 2013; 21(4):507-14.
-
Aravindan N, Thomas CR, Aravindan S, Mohan AS, Veeraraghavan J, Natarajan M. Irreversible EGFR inhibitor EKB-569 targets low-LET ?-radiation-triggered rel orchestration and potentiates cell death in squamous cell carcinoma. PLoS One. 2011; 6(12):e29705.
-
Aravindan N, Veeraraghavan J, Madhusoodhanan R, Herman TS, Natarajan M. Curcumin regulates low-linear energy transfer ?-radiation-induced NF?B-dependent telomerase activity in human neuroblastoma cells. Int J Radiat Oncol Biol Phys. 2011 Mar 15; 79(4):1206-15.
-
Tanaka M, Han S, Song H, Küpfer PA, Leumann CJ, Sonntag WE. An assay for RNA oxidation induced abasic sites using the Aldehyde Reactive Probe. Free Radic Res. 2011 Feb; 45(2):237-47.
-
Veeraraghavan J, Natarajan M, Herman TS, Aravindan N. Low-dose ?-radiation-induced oxidative stress response in mouse brain and gut: regulation by NF?B-MnSOD cross-signaling. Mutat Res. 2011 Jan 10; 718(1-2):44-55.